WGc-043 EBV mRNA vaccine

· Ruijin Hospital

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for WGc-043 EBV mRNA vaccine, covering 2025-04-02 to 2025-04-02. Get the full timeline:

Most recent: Clinical Trial Update: Mechanistic Study of EBV mRNA Vaccine (WGc-043) in EBV-Positive Relapsed/Refractory Lymphoma